Inhibition of cereblon by fenofibrate ameliorates alcoholic liver disease by enhancing AMPK
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yong Deuk | - |
dc.contributor.author | Lee, Kwang Min | - |
dc.contributor.author | Hwang, Seung-Lark | - |
dc.contributor.author | Chang, Hyeun Wook | - |
dc.contributor.author | Kim, Keuk-Jun | - |
dc.contributor.author | Harris, Robert A. | - |
dc.contributor.author | Choi, Hueng-Sik | - |
dc.contributor.author | Choi, Won-Sik | - |
dc.contributor.author | Lee, Sung-Eun | - |
dc.contributor.author | Park, Chul-Seung | - |
dc.date.accessioned | 2021-08-11T19:25:22Z | - |
dc.date.available | 2021-08-11T19:25:22Z | - |
dc.date.issued | 2015-12 | - |
dc.identifier.issn | 0925-4439 | - |
dc.identifier.issn | 1879-260X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10117 | - |
dc.description.abstract | Alcohol consumption exacerbates alcoholic liver disease by attenuating the activity of AMP-activated protein kinase (AMPK). AMPK is activated by fenofibrate, a peroxisome proliferator-activated receptor alpha (PPAR alpha) agonist, and inhibited by direct interaction with cereblon (CRBN), a component of an E3 ubiquitin ligase complex. Based on these preliminary findings, we investigated that CRBN would be up-regulated in the liver by alcohol consumption and that CRBN deficiency would ameliorate hepatic steatosis and pro-inflammatory responses in alcohol-fed mice by increasing AMPK activity. Wild-type, CRBN and PPAR alpha null mice were fed an alcohol-containing liquid diet and administered with fenofibrate. Gene expression profiles and metabolic changes were measured in the liver and blood of these mice. Expression of CRBN, cytochrome P450 2E1 (CYP2E1), lipogenic genes, pro-inflammatory cytokines, serum alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were increased in the Lieber-DeCarli alcohol-challenged mice. Fenofibrate attenuated the induction of CRBN and reduced hepatic steatosis and pro-inflammatory markers in these mice. Ablation of the gene encoding CRBN produced the same effect as fenofibrate. The increase in CRBN gene expression by alcohol and the reduction of CRBN expression by fenofibrate were negated in PPAR alpha null mice. Fenofibrate increased the recruitment of PPAR alpha on CRBN gene promoter in WT mice but not in PPAR alpha null mice. Silencing of AMPK prevented the beneficial effects of fenofibrate. These results demonstrate that activation of PPAR alpha by fenofibrate alleviates alcohol-induced hepatic steatosis and inflammation by reducing the inhibition of AMPK by CRBN. CRBN is a potential therapeutic target for the alcoholic liver disease. (C) 2015 Elsevier B.V. All rights reserved. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier BV | - |
dc.title | Inhibition of cereblon by fenofibrate ameliorates alcoholic liver disease by enhancing AMPK | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.bbadis.2015.09.014 | - |
dc.identifier.scopusid | 2-s2.0-84942848660 | - |
dc.identifier.wosid | 000363827300010 | - |
dc.identifier.bibliographicCitation | Biochimica et Biophysica Acta - Molecular Basis of Disease, v.1852, no.12, pp 2662 - 2670 | - |
dc.citation.title | Biochimica et Biophysica Acta - Molecular Basis of Disease | - |
dc.citation.volume | 1852 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 2662 | - |
dc.citation.endPage | 2670 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | ACTIVATED RECEPTOR-ALPHA | - |
dc.subject.keywordPlus | HEPATIC INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | FATTY LIVER | - |
dc.subject.keywordPlus | PPAR-ALPHA | - |
dc.subject.keywordPlus | MOLECULAR-MECHANISMS | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordPlus | PHOSPHORYLATION | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | INVOLVEMENT | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordAuthor | Cytokine | - |
dc.subject.keywordAuthor | Gene expression | - |
dc.subject.keywordAuthor | Inflammation | - |
dc.subject.keywordAuthor | PPAR alpha | - |
dc.subject.keywordAuthor | Steatosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.